Francisco Vasques‐Nóvoa

Nicotinamide for the treatment of heart failure with preserved ejection fraction

Mahmoud Abdellatif, Viktoria Trummer-Herbst, Franziska Koser et al. · Science Translational Medicine · 2021 · 192 citations · Full text

In vivo cyclic induction of the FOXM1 transcription factor delays natural and progeroid aging phenotypes and extends healthspan

Rui Ribeiro, Joana Catarina Macedo, Madalena Costa et al. · Nature Aging · 2022 · 78 citations

Lifespan Extension, Developmental Biology, Aging +12

Time course and mechanisms of left ventricular systolic and diastolic dysfunction in monocrotaline-induced pulmonary hypertension

Jorge Correia‐Pinto, Tiago Henriques‐Coelho, Roberto Roncon‐Albuquerque et al. · Basic Research in Cardiology · 2009 · 65 citations · Full text

Hypertension, Heart Failure, Cardiomyopathy +15

Risk of adverse events with liraglutide in heart failure with reduced ejection fraction: A post hoc analysis of the <scp>FIGHT</scp> trial

João Sérgio Neves, Francisco Vasques‐Nóvoa, Marta Borges‐Canha et al. · Diabetes Obesity and Metabolism · 2022 · 64 citations · Full text

Cardioprotective effects of early and late aerobic exercise training in experimental pulmonary arterial hypertension

Daniel Moreira‐Gonçalves, Rita Ferreira, Hélder Fonseca et al. · Basic Research in Cardiology · 2015 · 45 citations

Hypertension, Physical Activity, Kinesiology +15